CJC-1295 DAC

CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH), designed to elevate plasma levels of both growth hormone (GH) and insulin-like growth factor 1 (IGF-1). The addition of DAC (Drug Affinity Complex) significantly extends the peptide’s half-life in the bloodstream, allowing for sustained release and longer-lasting biological activity. This makes it a valuable compound for research focused on growth hormone regulation, metabolic function, and recovery processes.

Product Overview:

Our CJC-1295 with DAC is carefully lyophilized to maintain maximum stability and preserve its integrity for research applications. This long-acting peptide is produced under strict quality control protocols,

Formulated to meet the highest standards of biomedical and therapeutic research, CJC-1295 with DAC offers reliable performance for studies involving growth hormone pathways, peptide pharmacokinetics, and regenerative science.

Key Features:

• Precision lyophilization for enhanced shelf-life and stability
• Independently tested for ≥98% purity and consistency
• Ideal for research into growth hormone modulation and peptide-based therapies

Disclaimer: The following information is provided strictly for research purposes only. It is not intended for human or veterinary use outside of approved, controlled studies. Always follow applicable laws, institutional guidelines, and ethical standards.